
TOKYO -- Potential coronavirus treatment Avigan is now expected to take until July at the earliest to complete a clinical trial, further delaying government approval in Japan, Nikkei has learned.
Exclusive: Participants have reached only 70% of target level
TOKYO -- Potential coronavirus treatment Avigan is now expected to take until July at the earliest to complete a clinical trial, further delaying government approval in Japan, Nikkei has learned.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.